Valeritas

Valeritas, Inc., registered in Delaware on December 27, 2007. The company is engaged in the development of innovative technologies to improve the health and quality of life for people with type 2 diabetes. Its first commercialized product, the V-Go Disposable Insulin Delivery Device, or V-Go, assists patients with type 2 diabetes who require insulin injections to achieve and maintain their target blood glucose levels. The company is currently focused on the treatment of patients with type 2 diabetes.